Siemens Healthineers AG (OTCMKTS:SMMNY) Sees Large Decline in Short Interest

Posted by on May 12th, 2026

Siemens Healthineers AG (OTCMKTS:SMMNY – Get Free Report) was the target of a large drop in short interest during the month of April. As of April 30th, there was short interest totaling 8,769 shares, a drop of 82.5% from the April 15th total of 50,051 shares. Based on an average daily trading volume, of 410,091 shares, the days-to-cover ratio is currently 0.0 days.

Siemens Healthineers Price Performance

SMMNY stock opened at $19.71 on Tuesday. The company’s 50-day moving average is $21.70 and its 200-day moving average is $24.30. Siemens Healthineers has a 1 year low of $19.54 and a 1 year high of $28.92.

Siemens Healthineers (OTCMKTS:SMMNY – Get Free Report) last posted its quarterly earnings results on Thursday, May 7th. The company reported $0.31 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.29 by $0.02. The business had revenue of $6.68 billion during the quarter, compared to analyst estimates of $6.96 billion.

Wall Street Analyst Weigh In

A number of equities analysts have recently commented on SMMNY shares. Citigroup restated a “buy” rating on shares of Siemens Healthineers in a research report on Friday, January 23rd. Zacks Research upgraded shares of Siemens Healthineers from a “strong sell” rating to a “hold” rating in a research report on Monday, January 12th. Finally, Sanford C. Bernstein raised shares of Siemens Healthineers to a “strong-buy” rating in a research note on Tuesday, January 13th. Two equities research analysts have rated the stock with a Strong Buy rating, two have issued a Buy rating and two have assigned a Hold rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Buy”.

Check Out Our Latest Report on SMMNY

Siemens Healthineers Company Profile

(Get Free Report)

Siemens Healthineers AG is a leading global medical technology company that develops, manufactures and distributes a broad range of products and services for the healthcare sector. Headquartered in Erlangen, Germany, the company focuses on diagnostic and therapeutic imaging, in vitro diagnostics and advanced digital health solutions. As a spin-off from Siemens AG, Siemens Healthineers has leveraged decades of engineering expertise to establish a comprehensive portfolio that addresses critical needs in modern healthcare.

The company’s core offerings include magnetic resonance imaging (MRI), computed tomography (CT), X-ray and molecular imaging systems, as well as laboratory diagnostics equipment and point-of-care testing devices.

Read More

Receive News & Ratings for Siemens Healthineers Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Siemens Healthineers and related companies with MarketBeat.com's FREE daily email newsletter.